PharVision Advisers »

Stagwell shares owned by PharVision Advisers

Quarter-by-quarter ownership of Stagwell (STGW) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Stagwell

Tip: Access up to 7 years of quarterly data

All positions including Stagwell held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stagwell by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-03-31 $117k 19k 6.05
2024-12-31 $125k 19k 6.58

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Stagwell

Hotchkis and Wiley Capital Management
Madison Avenue Partners
BlackRock
Goldman Sachs Group
Vanguard Group
Robeco Investment Management
Dimensional Fund Advisors
Geode Capital Management
UBS Group
PENN Capital Management
State Street Corporation
ABLE Financial Group
Toron Capital Markets
Diversify Wealth Management
Jpmorgan Chase & Co

View all funds holding Stagwell